Pumas AI

Accelerated drug development

ACCURATE | INTEGRATED | POWERFUL

The fastest end-to-end pharmaceutical modeling and simulation platform for quantitative analysis across the drug development lifecycle.

Better data demands better analytics. Pumas is designed to help pharmaceutical researchers not just compute faster, but explore a wider range of questions for more valuable insight.

Pumas files are accepted by FDA for regulatory submissions.

We challenged the status quo

Why should the best minds in medical research settle for incremental improvements in technology and juggle a patchwork of programs that don’t talk to each other?

We dared to invent a platform on the latest technology that is accurate, integrated and powerful. And it is the fastest pharmaceutical modeling and simulation platform yet.

Key Features

One suite that does it all

All the analyses pharmaceutical scientists need in one powerful platform. Capabilities include non-compartmental analysis, bioequivalence, nonlinear mixed effects modeling and simulations.

NLME

NCA

PBPK

QSP

CTS

ML/DL

IVIVC

Deeper intelligence for sharper investment

Only 2% of pharmaceutical innovation successfully enters the market. Pumas multiplies your chances.

With its complete range of analytics capabilities, PUMAS gives pharmaceutical/biotech companies and their investors usable quantitative metrics on technical, regulatory, and commercial success probabilities. Users can translate predictive insight into real world decisions faster than ever before, effectively de-risking investments.

One powerful platform, Infinite potential.

ACCURATE

PUMAS is the world’s first platform that truly integrates mechanistic pharmacometric models with Scientific Machine Learning and convolutional neural networks. Our proprietary algorithms unravel hidden insight.

SUPERFAST

PUMAS crunches data 10 to 200x faster than the current standard. Turn predictive insight into critical decisions faster than ever before.

SIMPLE

Designed for intuitive use, even new users can build models with ease. With just one language for your entire drug development pipeline, PUMAS saves significant training and maintenance costs.

INTEGRATED

Every type of analysis scientists perform throughout the drug development lifecycle in one seamless environment. Why waste resources on multiple softwares?

SCALABLE

Highly scalable, PUMAS runs on all GPUs and any cloud computing setup in conjunction with JuliaTeam and JuliaRun. Leverage the language’s database, statistics, and visualization functionality — all without losing speed and power.

ACCESSIBLE

As researchers, we understand the need for affordable pricing. We want as many researchers as possible to benefit from PUMAS and have evolved licensing terms so accessibility doesn’t impede research.

PRO-RESEARCH

We strive to democratize tools of learning and research —PUMAS is available completely free of cost for non-commercial use by academicians and students.

The world’s leading businesses, research labs and universities are leveraging the power of Pumas

We have been using Pumas software for our pharmacometric needs to support our development decisions and regulatory submissions. Pumas software has surpassed our expectations on its accuracy and ease of use. We are encouraged by its capability of supporting different types of pharmacometric analyses within one software. Pumas has emerged as our "go-to" tool for most of our analyses in recent months. We also work with Pumas-AI on drug development consulting. We are impressed by the quality and breadth of the experience of Pumas-AI scientists in collaborating with us on modeling and simulation projects across our pipeline spanning investigational therapeutics and vaccines at various stages of clinical development

Director, Head of Clinical Pharmacology and Pharmacometrics, Moderna Therapeutics, Inc

Husain A. PhD

Recently we worked with Dr Gobburu and his team on applying Model-informed Drug Development (MIDD) approach to support the development of one of our key assets. This work led to a successful meeting with the FDA and shortening the drug development program tremendously. All the modeling and simulation work submitted and reviewed by the Agency was performed using Pumas software. We are very pleased with the experience, quality of the work and the outcome.

Sr. Vice President, Proprietary Products, Dr. Reddy's Laboratories Limited

Dr Anil Namboodiripad, PhD

Lack of easily accessible software stifles the ability to teach pharmacometrics. Maybe because Pumas is developed by academicians, software access is not a problem anymore. We are moving to Pumas for all our courses and research.

Academic Researcher

Pumas-AI developed a revolutionary platform for model based drug development which utilizes the powerful Julia programming language. Pumas utilizes the state of the art numerical capabilities of Julia for population PK and other types of analysis. It alleviates the need to switch between different programming languages since everything is self-contained within Julia. Data integration, model specification ,and postprocessing are easy and convenient. Pumas-AI product is a breath of fresh air and a real winner.

SENIOR PHARMACOKINETICIST, DATA AND MODELING SCIENCES, PROCTER & GAMBLE

Robert D. Johnson, PhD

VIDEOS

About Pumas-AI

Vijay Ivaturi | July 2020

Pumas in the Cloud

Matt Bauman | August 2020

DOCUMENTATION

Dive deep with our white papers, manuals and technical literature.

View Documentation

TUTORIALS

Step-by-step instructions to help you experience the full potential of our user-friendly modeling and simulation platform.

View Tutorials

COMMUNITY

Connect with Pumas users around the world. We’re listening to make our platform better for our community.

more Pumas on Discourse